Malaysia's Firstborn Top Capital to go public via $1.1B SPAC merger

What's the deal? ARC Group Acquisition I CorpDealroom has a profile for this one. Try Dealroom → (Nasdaq: ARCL), a special purpose acquisition company, has agreed to merge with Firstborn Top CapitalDealroom has a profile for this one. Try Dealroom →, a licensed Malaysian private financing company. The combined entity will be renamed BlueCrest Investment, Inc. and trade on the Nasdaq Global Market under the ticker "BCIN." The deal values Firstborn Top Capital at a pro forma enterprise value of roughly $1,091.2 million.

What each side brings: Firstborn Top Capital lends to individuals and businesses across Malaysia, offering one-working-day approval, fixed monthly interest, and loan terms up to five years. Under the agreement, all of its shareholders will sell 100% of their equity to ARCL, making the company a wholly owned subsidiary.

Who runs it? Executive Director Ow Ruey Shen will continue to lead Firstborn Top Capital. BlueCrest Investment will be led by chief executive officer and executive director Datuk Dr. Doris Wong Sing Ee, who also heads Nasdaq-listed Bio Green Med Solution, Inc. and holds a doctorate in business administration specialising in ESG.

What's the endgame? The transaction gives Firstborn Top Capital capital and a public platform to scale its lending operations. "This transaction positions us to do so on a much larger scale," Ow said, pointing to expansion across Malaysia and, eventually, Southeast Asia.

Why now? The business combination is expected to close in the first quarter of 2027. Wong said Firstborn Top Capital "stood out for its revenue model, strong management team, and compelling growth" after ARCL evaluated numerous potential targets.

The signal: The deal reflects continued appetite among Southeast Asian financial firms to reach US public markets through SPAC mergers, using a Nasdaq listing to fund regional expansion.

Image credit: Generated with Gemini